X4 Pharmaceuticals, Inc.XFORNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, above historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-27.58M
↑ 47% above average
Average (9y)
$-51.61M
Historical baseline
Range
High:$-12.35M
Low:$-94.89M
CAGR
+9.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-27.58M | +70.9% |
| 2023 | $-94.89M | -6.2% |
| 2022 | $-89.33M | -5.7% |
| 2021 | $-84.54M | -45.6% |
| 2020 | $-58.06M | -12.3% |
| 2019 | $-51.70M | -12.7% |
| 2018 | $-45.88M | -45.2% |
| 2017 | $-31.60M | -56.8% |
| 2016 | $-20.16M | -63.3% |
| 2015 | $-12.35M | - |